Although this study confirms that the prevalence of insulin resistance amongst women with PCOS is high, it has not been able to prove that serum adiponectin can be used as a surrogate marker for insulin resistance in women with PCOS. The gene discussed is ADIPOQ; the disease is polycystic ovary syndrome.